Sign Out
Gemigliptin tablet 50 mg is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated in adults aged 18-75 years with type 2 diabetes mellitus.
Gemigliptin tablet 50 mg can be administered: As monotherapy: as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.
As dual therapy in combination with: metformin as initial therapy in treatment naive patients inadequately glycaemic control by diet and exercise alone; metformin in patients with inadequate glycaemic control with maximal tolerated dose of metformin alone.
As triple therapy in combination with: metformin and sulfonylurea in patients with inadequate glycaemic control with the maximal tolerated dose of metformin and sulfonylurea dual therapy.
Continue with Google